Sigyn Therapeutics, Inc. (SIGY)
OTCMKTS
· Delayed Price · Currency is USD
4.150
+0.150 (3.75%)
Mar 31, 2025, 3:31 PM EST
Sigyn Therapeutics Employees
Sigyn Therapeutics had 5 employees as of December 31, 2023. The number of employees increased by 1 or 25.00% compared to the previous year.
Employees
5
Change (1Y)
1
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$798,689
Market Cap
6.66M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5 | 1 | 25.00% |
| Dec 31, 2022 | 4 | -1 | -20.00% |
| Dec 31, 2021 | 5 | 3 | 150.00% |
| Dec 31, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 413 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 9 |
| Silence Therapeutics | 116 |
| American Oncology Network | 1,525 |
Sigyn Therapeutics News
- 7 weeks ago - Sigyn Therapeutics to Present at Tomorrow's Small Cap Growth Virtual Investor Conference - GlobeNewsWire
- 8 months ago - Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now - GlobeNewsWire
- 1 year ago - Sigyn Therapeutics™ to Present at Tomorrow's Emerging Growth Conference - GlobeNewsWire
- 1 year ago - Sigyn Therapeutics™ Announces Filing of 2023 Annual Report on SEC Form 10-K - GlobeNewsWire
- 1 year ago - Sigyn Therapeutics Completes Reverse Stock Split - GlobeNewsWire
- 1 year ago - Sigyn Therapeutics Announces Reverse Stock Split - GlobeNewsWire
- 1 year ago - Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officer - GlobeNewsWire
- 1 year ago - Sigyn Therapeutics Reports Third Quarter 2023 Financial Results - GlobeNewsWire